Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  MAP Pharmaceuticals Inc.    MAPP   US56509R1086

SummaryNewsCalendarCompanyFinancialsForum 
Income Statement Evolution
MAP Pharmaceuticals Inc. : Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 200920102011201220132014
Sales54,2-23,1---
Operating income (EBITDA)-5,49-52,3-31,2---
Operating profit (EBIT)-6,97-53,5-32,7---
Pre-Tax Profit (EBT)---32,9---
Net income-9,00-54,7-32,9---
EPS ( $)-0,41-2,01-1,08---
Dividend per Share ( $)------
Yield------
Announcement Date03/02/2010
12:02pm
03/01/2011
12:00pm
03/29/2012
11:00am
---
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 200920102011201220132014
Debt------
Finance-68,498,8---
Operating income (EBITDA)-5,49-52,3-31,2---
Leverage
(Debt/EBITDA)
------
Capital Expenditure-2,801,75---
Book Value Per Share (BVPS)-2,07 $1,29 $---
Cash Flow per Share-0,18 $-1,81 $0,98 $---
Announcement Date03/02/2010
12:02pm
03/01/2011
12:00pm
03/29/2012
11:00am
---
Assessed data source :
© 2013 Thomson Reuters
Advertisement
EPS & Dividend
MAP Pharmaceuticals Inc. : EPS Dividend
Dynamic quotes  
ON
| OFF
Copyright © 2013 Surperformance. All rights reserved.